Weight Loss Jabs: The Reality When Treatment Stops
New medical research reveals the sobering reality for patients discontinuing popular weight loss injections like Ozempic and Wegovy, with most regaining significant weight within months.
New medical research reveals the sobering reality for patients discontinuing popular weight loss injections like Ozempic and Wegovy, with most regaining significant weight within months.
Exclusive: Costco pharmacies begin selling revolutionary weight loss injections Wegovy and Ozempic at competitive prices, making groundbreaking treatments more accessible across Britain.
Warehouse giant Costco is now offering substantial discounts on popular weight loss medications Ozempic and Wegovy, making groundbreaking treatments more accessible to consumers across the UK.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
Groundbreaking research reveals the hidden biological mechanisms that make sustained weight loss difficult, offering new hope for obesity treatment and diabetes prevention.
Exclusive investigation reveals how drug companies are profiting from body shame through Ozempic and Wegovy injections, while eating disorder experts warn of potentially devastating health consequences.
Pfizer announces a surprising turnaround in its weight-loss strategy, advancing two new daily pills in a heated battle for the lucrative obesity drug market dominated by injectables.
Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.
Exclusive: The NHS faces a financial timebomb as new analysis reveals prescribing weight-loss drugs like Wegovy could cost twice the entire current GP prescribing budget, sparking a national rationing debate.
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.
Medical experts reveal why miracle weight-loss drugs like Ozempic are failing to address the psychological roots of emotional eating, calling for integrated mental health support alongside pharmaceutical treatments.
Groundbreaking research reveals that blockbuster weight-loss jabs do more than suppress appetite—they may fundamentally change the brain's response to food, offering new hope for tackling compulsive eating disorders.
A new oral weight loss drug, Orforglipron, shows staggering results in a major clinical trial, offering a powerful and convenient alternative to injectable treatments for obesity.
A revolutionary new weight loss pill, Survodutide, is making waves in medical trials, with manufacturers boasting it could be twice as effective as blockbuster drugs like Ozempic and Wegovy.
New research reveals that GLP-1 weight-loss injections not only aid in shedding pounds but also significantly quiet intrusive thoughts about food, offering a dual benefit for patients.
Groundbreaking NHS research reveals obesity injections like Wegovy are dramatically more effective than lifestyle changes alone for teenagers, offering new hope in the childhood obesity crisis.
Groundbreaking UK research suggests GLP-1 weight-loss injections, including Wegovy, may dramatically reduce the risk of obesity-related cancers, offering new hope in preventative oncology.
The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.
The NHS receives a powerful new weapon in the fight against obesity as medical regulators approve a higher 2.4mg dose of Wegovy, proven to help patients shed significantly more weight.
A British mother who lost eight stone using 'fat jabs' has sparked a fierce debate by arguing the NHS should not fund them for weight loss, calling it a personal lifestyle choice rather than an essential right.
Discover how one man rejected extreme diets and lost a life-changing 14 stone with a simple, sustainable WeightWatchers plan. His journey from 27st to 13st is an inspiration for anyone struggling with weight loss.
Media mogul Oprah Winfrey reveals the secret behind her dramatic 42-pound weight loss, crediting a medical weight-management programme and a powerful shift in her perspective on obesity as a disease, not a character flaw.
UK travellers using Ozempic, Wegovy, or Mounjaro face a critical insurance loophole. Experts reveal how these popular weight-loss and diabetes injections could leave you unprotected and facing massive medical bills abroad.
UK health officials issue urgent safety alert for popular slimming injections like Ozempic and Wegovy. Patients must disclose use before operations to prevent dangerous complications.
Danish pharmaceutical giant Novo Nordisk announces major £90 million expansion at its Gatwick facility to meet soaring global demand for its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, creating new high-skilled jobs.
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
A leading UK pharmacist has revealed a powerful natural supplement, Berberine, dubbing it a revolutionary alternative to Ozempic for natural fat loss and blood sugar control.